Moderna Therapeutics Funding: $650M Raised, Series G (2018)
Moderna Therapeutics is based in Cambridge, Massachusetts. It has raised $650M in total funding. Latest round: Series G.
Moderna Therapeutics funding overview
Moderna Therapeutics is based in Cambridge, Massachusetts. Moderna Therapeutics has raised $650M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series G announced in January 2018. The round record for Moderna Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include Viking Global Investors LP, Invus, RA Capital Management, Wellington Management Company, LLP, AstraZeneca, Alexion Pharmaceuticals and 1 others. 7 distinct backers are named across the disclosed rounds.
Moderna Therapeutics at a glance
Total raised
$650M
Latest round
Series G
Latest round date
January 2018
Headquarters
Cambridge, Massachusetts
Notable investors
Viking Global Investors LP, Invus, RA Capital Management, Wellington Management Company, LLP, AstraZeneca, Alexion Pharmaceuticals, Endeavor Venture Funds
Frequently asked about Moderna Therapeutics funding
How much has Moderna Therapeutics raised?
Moderna Therapeutics has raised $650M in total disclosed funding across the rounds on record.
Who has invested in Moderna Therapeutics?
Viking Global Investors LP, Invus, RA Capital Management, Wellington Management Company, LLP, AstraZeneca, Alexion Pharmaceuticals are named among the investors backing Moderna Therapeutics.
What was the latest Moderna Therapeutics funding round?
The most recent disclosed round is a Series G, announced in January 2018.
Where is Moderna Therapeutics based?
Moderna Therapeutics is based in Cambridge, Massachusetts.
When did Moderna Therapeutics last raise?
The last disclosed Moderna Therapeutics round closed in January 2018 at Series G.
Round data for Moderna Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.
